Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn’s Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab

Open Access

Peer-reviewed

Research Article

Dario Sorrentino ,

* E-mail: drsorrentino@carilionclinic.org

Affiliations IBD Center, Division of Gastroenterology, Virginia Tech-Carilion School of Medicine, Roanoke, Virginia, United States of America, Department of Clinical and Experimental Medical Sciences, University of Udine School of Medicine, Udine, Italy
⨯
Marco Marino,

Affiliation Department of Clinical and Experimental Medical Sciences, University of Udine School of Medicine, Udine, Italy
⨯
Themistocles Dassopoulos,

Affiliation Baylor Center for IBD, Baylor University Medical Center, Dallas, Texas, United States of America
⨯
Dimitra Zarifi,

Affiliation Department of Clinical and Experimental Medical Sciences, University of Udine School of Medicine, Udine, Italy
⨯
Tiziana Del Bianco

Affiliation Department of Clinical and Experimental Medical Sciences, University of Udine School of Medicine, Udine, Italy
⨯

Reader Comments (0)

Endoscopy
Is the Subject Area "Endoscopy" applicable to this article?

Thanks for your feedback.
Surgical and invasive medical procedures
Is the Subject Area "Surgical and invasive medical procedures" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Colonoscopy
Is the Subject Area "Colonoscopy" applicable to this article?

Thanks for your feedback.
Crohn's disease
Is the Subject Area "Crohn's disease" applicable to this article?

Thanks for your feedback.
Inflammatory diseases
Is the Subject Area "Inflammatory diseases" applicable to this article?

Thanks for your feedback.
Pharmacokinetics
Is the Subject Area "Pharmacokinetics" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.